Every Form 4 that Monroe Fed Bancorp Inc (MFBI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MFBI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MFBI filings page.
Monroe Federal Bancorp, Inc. President & CEO Renollet Lewis reported receiving new equity awards. On January 26, 2026, he was granted 3,948 shares of common stock at no cost and stock options for 13,160 shares with an exercise price of $11.79 per share.
The restricted stock and options each vest at a rate of 20% per year starting January 26, 2027. After these grants, Lewis directly holds 3,948 common shares and 13,160 options, and is also shown with indirect beneficial ownership of shares held by an IRA, spouse, and an ESOP account.
Monroe Federal Bancorp, Inc. reported that its CFO and Treasurer, Lisa M. Bird, received new equity awards on January 26, 2026. She acquired 1,737 shares of common stock as a restricted stock grant at a price of $0 per share, all held directly.
She was also granted stock options on 5,790 shares of common stock at an exercise price of $11.79 per share, with 5,790 options beneficially owned directly after the transaction. Both the restricted stock and the options vest at a rate of 20% per year beginning on January 26, 2027.
Monroe Federal Bancorp, Inc. executive Christina R. Hassink, VP and COO, reported equity compensation grants dated January 26, 2026. She received 1,105 shares of common stock at $0 per share and 3,685 stock options with an exercise price of $11.79 per share.
The restricted shares and options each vest at a rate of 20% per year starting on January 26, 2027. Following these grants, Hassink directly holds 1,105 common shares and 3,685 options, and indirectly holds 5,000 common shares through an IRA and 137 common shares through an ESOP.
Monroe Federal Bancorp, Inc. VP of Commercial Lending, Thompson Douglas E., reported receiving equity awards in the form of common stock and stock options. On January 26, 2026, he acquired 1,105 shares of common stock at a price of $0, held directly.
He was also granted 3,685 stock options with an exercise price of $11.79 per share, expiring between January 26, 2027 and January 26, 2036. Both the restricted stock and options vest at a rate of 20% per year starting January 26, 2027. In addition, he indirectly holds 3,900 shares of common stock through an IRA and 183 shares through an ESOP.
Monroe Federal Bancorp, Inc. reported an equity compensation grant to VP - Retail Banking James C. Conley on January 26, 2026. He received 1,105 shares of restricted common stock at $0 and 3,685 stock options with an exercise price of $11.79 per share.
The restricted shares and options each vest at a rate of 20% per year starting January 26, 2027. After this award, Conley holds 1,605 common shares directly, plus 1,000 shares through an IRA and 124 shares through an ESOP.
Monroe Federal Bancorp, Inc. director and Chairman of the Board reported new equity awards in company stock. On December 18, 2025, the insider acquired 789 shares of common stock as an award at a stated price of $0, bringing direct ownership to 15,789 common shares. In addition, the insider reports 5,000 shares held indirectly by a spouse.
The filing also shows a new grant of stock options on 2,632 shares of common stock at an exercise price of $10.75 per share. Both the restricted stock and the options vest in equal 20% annual installments starting December 18, 2026, with the options expiring on December 18, 2035. These details outline the structure and timing of the director’s long-term incentive compensation in Monroe Federal Bancorp stock.
Monroe Federal Bancorp, Inc. reported that one of its directors acquired new equity awards on December 18, 2025. The director received 789 shares of restricted common stock at a price of $0, increasing the directly held common shares to 789. In addition, the director holds indirect common stock positions through a trust, an IRA, and a Roth IRA.
The filing also shows a grant of 2,632 stock options with an exercise price of $10.75 per share, exercisable through December 18, 2035. Both the restricted stock and these options vest at a rate of 20% per year starting on December 18, 2026, meaning the director earns these rights gradually over time.
Monroe Federal Bancorp, Inc. director reported new equity incentives in the form of restricted stock and stock options. On December 18, 2025, the reporting person acquired 789 shares of common stock as restricted stock at a stated price of $0, bringing their directly held common stock to 15,789 shares after the transaction.
The filing also shows a grant of stock options on 2,632 shares of common stock at an exercise price of $10.75 per share, dated December 18, 2025. Both the restricted shares and the options vest at a rate of 20% per year starting on December 18, 2026, which spreads the benefit of these awards over several years.
Monroe Federal Bancorp director reports new stock and option awards. A director of Monroe Federal Bancorp, Inc. received 789 shares of common stock on December 18, 2025 at a stated price of $0, increasing direct holdings to 2,289 shares. The director also holds 6,000 shares indirectly through a deferred compensation plan.
On the same date, the director was granted 2,632 stock options with an exercise price of $10.75 per share, expiring on December 18, 2035. Both the 789 restricted shares and the 2,632 options vest in installments of 20% per year starting on December 18, 2026, creating a long-term equity incentive tied to continued service.
Monroe Federal Bancorp, Inc. director reported new equity awards and updated holdings. On December 18, 2025, the director acquired 789 shares of common stock at a reported price of $0, reflected as direct ownership. The filing also shows indirect ownership of 10,000 shares through a spouse and 15,000 shares through a deferred compensation plan.
On the same date, the director received stock options for 2,632 shares with an exercise price of $10.75 per share, exercisable from December 18, 2026 and expiring on December 18, 2035. Both the restricted stock and the stock options vest at a rate of 20% per year starting on December 18, 2026, indicating a multi‑year incentive structure tied to continued service.
Monroe Federal Bancorp, Inc. reported an insider equity award to a director. On 12/18/2025, the director acquired 789 shares of common stock as an award classified as an acquisition at a price of $0 per share, bringing their directly held common stock to 15,789 shares after the transaction. The filing also shows the grant of 2,632 stock options with an exercise price of $10.75 per share, all held directly.
The restricted stock and options both vest at a rate of 20% per year starting on December 18, 2026, meaning the director’s ability to fully access these awards is spread over five years. This filing reflects routine director compensation and does not involve any sale of existing shares.